Reposal: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Reposal": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
||
| Line 33: | Line 33: | ||
== References == | == References == | ||
{{reflist|2}} | |||
{{chem-stub}} | {{chem-stub}} | ||
Revision as of 14:25, 6 September 2012
 | |
| Clinical data | |
|---|---|
| Synonyms | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C14H18N2O3 |
| Molar mass | 262.304 g/mol |
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. [1] [2]
References
- ↑ Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) Ugeskrift for Læger. 1963 Dec 6;125:1735-1741.
- ↑ Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Barbiturates
- Sedatives